License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals make the process as quick and easy as possible.

Use the Technology Explorer below to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.

Deep Tech Download Newsletter

For the latest on active investment opportunities and developments at companies emerging from U of T Research, sign up for the Deep Tech Download newsletter. With more than $1.5 billion raised by research-based companies in the last 5 years, Deep Tech Download is your inside track to get involved!

Technology Explorer

Technology Keywords
Recombinant Antibodies Network (RAN) Antibodies , Cancer , Advanced Health Technologies , Biotechnology , Pharmaceuticals , Therapeutics 
NUAK Inhibitors as Therapeutics for Cancer and Fibrosis Advanced Health Technologies , Biotechnology , Cancer , Cell Signaling , Drug Discovery , Health & Related Life Sciences , Inflammation , Pharmaceuticals , Small Molecules , Therapeutics , Oncology , Fibrosis 
Inhibition of PKN1 As Therapy For Chronic Lymphocytic Leukemia (CLL) Advanced Health Technologies , Biotechnology , Cancer , Drug Discovery , Health & Related Life Sciences , Leukemia , Pharmaceuticals , Small Molecules , Therapeutics 
An Improved CRISPR-Cas System for Systemic and Combinatorial Genome Wide Screens Advanced Health Technologies , Drug Discovery , Functional Genomics , Gene Editing , Gene Expression , Genetics , Health & Related Life Sciences , molecular mechanisms , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Research Tools , Genetic interactions 
Boron Containing Bioactive Biomolecules Chemical Synthesis , Drug Discovery , Health & Related Life Sciences , Pharmaceuticals , Small Molecules , Therapeutics 
Cryosparc: Accelerated Protein Structure Determination from Cryo-EM 3D imaging , Advanced Health Technologies , Artificial Intelligence (AI) , Companies , Drug Discovery , Electron Microscopy , Machine Learning , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Proteins , Research Tools , Software 
Portable Automated Manufacturing of Protein-Based Therapeutics Pharmaceutical Research / Manufacturing , Pharmaceuticals , Point-of-Care , Proteins , Regenerative Medicine , Therapeutics 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515